Pfizer
Utility Patents
Last updated:
List of all Pfizer patents 177 in total
| Status | Patent |
|---|---|
Grant | Utility: PD-1/PD-L1 inhibitors for the treatment of cancer Filling date: 13 Sep 2025 Issue date: 13 Oct 2020 |
Grant | Utility: Bicyclic-fused heteroaryl or aryl compounds Filling date: 13 Sep 2025 Issue date: 6 Oct 2020 |
Grant | Utility: Therapeutic antibodies and their uses Filling date: 13 Sep 2025 Issue date: 6 Oct 2020 |
Grant | Utility: Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors Filling date: 13 Sep 2025 Issue date: 29 Sep 2020 |
Grant | Utility: Immunogenic compositions for use in pneumococcal vaccines Filling date: 13 Sep 2025 Issue date: 29 Sep 2020 |
Grant | Utility: Compositions and methods relating to a mutant clostridium difficile toxin Filling date: 13 Sep 2025 Issue date: 29 Sep 2020 |
Grant | Utility: Cyclin dependent kinase inhibitors Filling date: 13 Sep 2025 Issue date: 8 Sep 2020 |
Grant | Utility: Immunogenic compositions and uses thereof Filling date: 13 Sep 2025 Issue date: 25 Aug 2020 |
Grant | Utility: Glycoconjugation process Filling date: 13 Sep 2025 Issue date: 18 Aug 2020 |
Grant | Utility: 6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compounds Filling date: 13 Sep 2025 Issue date: 11 Aug 2020 |
Grant | Utility: Anti-IL-2 antibodies and compositions and uses thereof Filling date: 13 Sep 2025 Issue date: 11 Aug 2020 |
Grant | Utility: Diagnostic anti-PD-L1 antibody and use thereof Filling date: 13 Sep 2025 Issue date: 11 Aug 2020 |
Grant | Utility: Cells having reduced BCAT1 Filling date: 13 Sep 2025 Issue date: 11 Aug 2020 |
Grant | Utility: 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors Filling date: 13 Sep 2025 Issue date: 28 Jul 2020 |
Grant | Utility: Solid forms of a selective CDK4/6 inhibitor Filling date: 13 Sep 2025 Issue date: 28 Jul 2020 |
Grant | Utility: Tubulysin analogs and methods for their preparation Filling date: 13 Sep 2025 Issue date: 28 Jul 2020 |
Grant | Utility: Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2- -methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof Filling date: 13 Sep 2025 Issue date: 14 Jul 2020 |
Grant | Utility: SGLT-2 inhibitors for treating metabolic disorders in patients with renal impairment or chronic kidney disease Filling date: 13 Sep 2025 Issue date: 14 Jul 2020 |
Grant | Utility: Substituted carbonucleoside derivatives useful as anticancer agents Filling date: 13 Sep 2025 Issue date: 14 Jul 2020 |
Grant | Utility: Pyrrolo[2,3-D]pyrimidinyl, pyrrolo[2,3-B]pyrazinyl, pyrrolo[2,3-B]pyridinyl acrylamides and epoxides thereof Filling date: 13 Sep 2025 Issue date: 7 Jul 2020 |
Grant | Utility: Heteroaromatic compounds and their use as dopamine D1 ligands Filling date: 13 Sep 2025 Issue date: 30 Jun 2020 |
Grant | Utility: Dual-ended lip balm container Filling date: 13 Sep 2025 Issue date: 30 Jun 2020 |
Grant | Utility: Combination of a PD-1 antagonist and an ALK inhibitor for treating cancer Filling date: 13 Sep 2025 Issue date: 30 Jun 2020 |
Grant | Utility: Site specific HER2 antibody drug conjugates Filling date: 13 Sep 2025 Issue date: 23 Jun 2020 |
Grant | Utility: GLP-1 receptor agonists and uses thereof Filling date: 13 Sep 2025 Issue date: 16 Jun 2020 |
Grant | Utility: GLP-1 receptor agonists and uses thereof Filling date: 13 Sep 2025 Issue date: 9 Jun 2020 |
Grant | Utility: Cycloalkyl-linked diheterocycle derivatives Filling date: 13 Sep 2025 Issue date: 9 Jun 2020 |
Grant | Utility: Imidazopyridazine compounds Filling date: 13 Sep 2025 Issue date: 2 Jun 2020 |
Grant | Utility: GLP-1 receptor agonists and uses thereof Filling date: 13 Sep 2025 Issue date: 2 Jun 2020 |
Grant | Utility: Immunogenic glycoprotein conjugates Filling date: 13 Sep 2025 Issue date: 2 Jun 2020 |
Grant | Utility: Substituted quinazoline and pyridopyrimidine derivatives useful as anticancer agents Filling date: 13 Sep 2025 Issue date: 26 May 2020 |
Grant | Utility: Formulations of a PI3K/mTOR-inhibitor for intravenous administration Filling date: 13 Sep 2025 Issue date: 26 May 2020 |
Grant | Utility: Methods for purifying FXa variant proteins Filling date: 13 Sep 2025 Issue date: 26 May 2020 |
Grant | Utility: Capped and uncapped antibody cysteines, and their use in antibody-drug conjugation Filling date: 13 Sep 2025 Issue date: 19 May 2020 |
Grant | Utility: Immunogenic compositions for use in pneumococcal vaccines Filling date: 13 Sep 2025 Issue date: 19 May 2020 |
Grant | Utility: Humanized antibodies Filling date: 13 Sep 2025 Issue date: 12 May 2020 |
Grant | Utility: Tofacitinib oral sustained release dosage forms Filling date: 13 Sep 2025 Issue date: 5 May 2020 |
Grant | Utility: 4-1BB binding molecules Filling date: 13 Sep 2025 Issue date: 5 May 2020 |
Grant | Utility: 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives as MAGL inhibitors Filling date: 13 Sep 2025 Issue date: 21 Apr 2020 |
Grant | Utility: Synergistic auristatin combinations Filling date: 13 Sep 2025 Issue date: 14 Apr 2020 |
Grant | Utility: Human cytomegalovirus gB polypeptide Filling date: 13 Sep 2025 Issue date: 7 Apr 2020 |
Grant | Utility: 5,7-dihydro-pyrrolo-pyridine derivatives Filling date: 13 Sep 2025 Issue date: 31 Mar 2020 |
Grant | Utility: Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2- -methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof Filling date: 13 Sep 2025 Issue date: 17 Mar 2020 |
Grant | Utility: Tetrahydroquinazoline derivatives useful as anticancer agents Filling date: 13 Sep 2025 Issue date: 17 Mar 2020 |
Grant | Utility: Compositions and methods for counteracting Factor Xa inhibition Filling date: 13 Sep 2025 Issue date: 17 Mar 2020 |
Grant | Utility: 6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine dopamine D3 ligands Filling date: 13 Sep 2025 Issue date: 17 Mar 2020 |
Grant | Utility: Therapeutic nanoparticles comprising a protonatable nitrogen therapeutic agent and methods of making and using same Filling date: 13 Sep 2025 Issue date: 10 Mar 2020 |
Grant | Utility: Glycoconjugation processes and compositions Filling date: 13 Sep 2025 Issue date: 10 Mar 2020 |
Grant | Utility: Substituted dihydroisoquinolinone compounds Filling date: 13 Sep 2025 Issue date: 25 Feb 2020 |
Grant | Utility: Muteins of clotting factor VIII Filling date: 13 Sep 2025 Issue date: 25 Feb 2020 |
Showing 100 to 150 of 177 patents.